Contiguous gene deletion of chromosome 2p16.3-p21 as a cause of Lynch syndrome

[1]  S. Gruber,et al.  Elevated risk of prostate cancer among men with Lynch syndrome. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  R. Schimke,et al.  Regarding cancer predisposition detected by CHG arrays , 2011, Genetics in Medicine.

[3]  L. Shaffer,et al.  Response to the letter by Collins and Schimke , 2011, Genetics in Medicine.

[4]  Aung Ko Win,et al.  Metachronous colorectal cancer risk for mismatch repair gene mutation carriers: the advantage of more extensive colon surgery , 2010, Gut.

[5]  H T Lynch,et al.  Review of the Lynch syndrome: history, molecular genetics, screening, differential diagnosis, and medicolegal ramifications , 2009, Clinical genetics.

[6]  L. Shaffer,et al.  Impact of genotype-first diagnosis: the detection of microdeletion and microduplication syndromes with cancer predisposition by aCGH , 2009, Genetics in Medicine.

[7]  A. Crucitti,et al.  A novel microdeletion syndrome with loss of the MSH2 locus and hereditary non‐polyposis colorectal cancer , 2004, Clinical genetics.

[8]  A. Dawson,et al.  Interstitial deletion of chromosome 2p16.2p21 , 2003, Clinical dysmorphology.

[9]  S. Zeuzem,et al.  A de novo deletion of chromosome 5q causing familial adenomatous polyposis, dysmorphic features, and mild mental retardation , 2001, American Journal of Gastroenterology.

[10]  Huntington F. Willard,et al.  Thompson and Thompson Genetics in Medicine , 2001 .

[11]  J. Fryns,et al.  Interstitial deletion 2p accompanied by marker chromosome formation of the deleted segment resulting in a stable acentric marker chromosome. , 1997, Genetic counseling.

[12]  A. Sandberg,et al.  Gardner syndrome in a man with an interstitial deletion of 5q. , 1986, American journal of medical genetics.